TY - JOUR
T1 - Prognosis-based management of unexplained infertility-why not?
AU - Shingshetty, Laxmi
AU - Wang, Rui
AU - Feng, Qian
AU - Maheshwari, Abha
AU - Mol, Ben W.
N1 - Funding Information:
BWM is supported by a NHMRC Investigator grant (GNT1176437). BWM reports consultancy and travel support from Merck and Organon, Norgine, and research funding from Merck. BWM reports holding stock from ObsEva. QF reports receiving a scholarship from Merck. RW is supported by an NHMRC Emerging Leadership Investigator grant (2009767). AM is supported by NIHR HTA UK for conducting the E-Freeze trial, travel support for lectures from Merck Serono, Cook, Ferring. AM reports support for attending meetings and travel from Ferring, Pharmasure and Gedeon Ritcher and Participation on a Data Safety Monitoring Board or Advisory Board for Ferring and Merck Serono. LS reports travel support for lectures and a workshop from Ferring and Cook.
Publisher Copyright:
© The Author(s) 2024.
PY - 2024/3
Y1 - 2024/3
N2 - Up to a half of couples seeking medical assistance for infertility are diagnosed with unexplained infertility, characterized by normal ovulation, tubal patency, and semen analysis results. This condition presents a challenge in determining the optimal treatment approach. Available treatments include IUI and IVF, but guidelines vary on when to offer each. Prognosis-based management is identified as a research priority, and various prediction models have been developed to guide treatment decisions. Prognostic factors include female age, duration of subfertility, and sperm parameters, among others. Prognosis-based strategies can enhance cost-effectiveness, safety, and patient outcomes, offering less invasive options to those with good prognoses and more aggressive interventions to those with poor prognoses. However, there is a gap between research evidence and its clinical application. In this article, we discuss the application of prognosis-based management in the context of unexplained infertility, highlighting its potential to improve clinical decision-making and patient outcomes.
AB - Up to a half of couples seeking medical assistance for infertility are diagnosed with unexplained infertility, characterized by normal ovulation, tubal patency, and semen analysis results. This condition presents a challenge in determining the optimal treatment approach. Available treatments include IUI and IVF, but guidelines vary on when to offer each. Prognosis-based management is identified as a research priority, and various prediction models have been developed to guide treatment decisions. Prognostic factors include female age, duration of subfertility, and sperm parameters, among others. Prognosis-based strategies can enhance cost-effectiveness, safety, and patient outcomes, offering less invasive options to those with good prognoses and more aggressive interventions to those with poor prognoses. However, there is a gap between research evidence and its clinical application. In this article, we discuss the application of prognosis-based management in the context of unexplained infertility, highlighting its potential to improve clinical decision-making and patient outcomes.
KW - expectant management
KW - in vitro fertilization
KW - intra-uterine insemination
KW - live birth
KW - prediction models
KW - prognostic models
KW - unexplained infertility
UR - http://www.scopus.com/inward/record.url?scp=85190237844&partnerID=8YFLogxK
U2 - 10.1093/hropen/hoae015
DO - 10.1093/hropen/hoae015
M3 - Comment / Debate
AN - SCOPUS:85190237844
SN - 2399-3529
VL - 2024
JO - Human Reproduction Open
JF - Human Reproduction Open
IS - 2
M1 - hoae015
ER -